Is the quality of the Laos-ASEAN version of tepotinib generic drug reliable? What is the current selling price per box?
Tepotinib (Tepotinib), as an oral MET kinase inhibitor, is specially designed for patients with metastatic non-small cell lung cancer (NSCLC) carrying MET exon 14 skipping mutations. By precisely blocking the MET signaling pathway, it can effectively curb the growth and spread of tumor cells, opening up a new treatment path for these patients.
Among the many generic drugs of tepotinib, the Lao ASEAN version has attracted much attention from patients due to its high market awareness and reliable quality control. So, what is the quality of this generic drug? Laos ASEAN Pharmaceutical Company has always adhered to the high standards of international pharmaceutical production quality management. From the selection of raw materials to the delivery of finished products, every process is subject to strict quality control to ensure that every drug can achieve the best quality. Therefore, patients can use it with confidence and its quality is guaranteed.
As for price, the specifications of the Laos-ASEAN version of generic Tepotinib are225mg*60 tablets, and the current market price is about more than 9,000 yuan. Compared with the high cost of the original drug, this price undoubtedly greatly reduces the financial pressure on patients, allowing more patients to afford this effective treatment.
Of course, patients still need to be vigilant when purchasing the Lao ASEAN version of Tepotinib generics, and be sure to purchase through formal channels to avoid the risk of counterfeit drugs. At the same time, during the medication process, patients should strictly follow the doctor's prescription instructions, take the medication according to the prescribed dosage and time, and pay close attention to the body's reaction. If you have any discomfort or abnormality, you should report it to your doctor promptly so that you can receive professional treatment and advice.
In general, the Laos-ASEAN version of tepotinib generic drug, with its reliable quality and affordable price, provides new treatment hope for non-small cell lung cancer patients carryingMET exon 14 skipping mutations. When choosing, patients should fully understand the relevant information of the drug and use it rationally under the guidance of a doctor in order to obtain the best therapeutic effect.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)